share-based payment: ifrs 2 wiecek and young ifrs primer chapter 29

Share-based Payment: IFRS 2

Wiecek and Young

IFRS PrimerChapter 29

2

Share-based Payment

Related standards IFRS 2 Current GAAP comparisons Looking ahead End-of-chapter practice

3

Related Standards

FAS 123 Share-based Payment

4

IFRS 2 – Overview

Objective and scope Recognition Equity-settled share-based payment transactions Cash-settled share-based payment transactions Share-based payment transactions with cash

alternatives Summary Disclosures

5

IFRS 2 – Objective and Scope Deals with transactions where equity instruments are used as

consideration

Entities must recognize these types of transactions– If they create liabilities, they must be remeasured after the transaction date

Examples of share-based payment transactions– Remunerative option plans such as employee stock options plans– Acquisitions where shares are used as consideration– Situations where services are paid for with equity instruments

Accounting for employee remuneration plans can be complex – These plans often span numerous reporting periods – Cost to the entity may be difficult to measure depending on the terms of the plans

6

IFRS 2 – Objective and Scope The standard puts all share-based transactions into three categories The definitions for the first two categories follow

7

IFRS 2 – Objective and Scope The third category is where there is a choice to settle in cash or equity

– Either the entity has the option to determine whether to settle the transaction in cash or equity, or the counterparty has this option

Share-based payment transactions– Defined as transactions in which the entity receives goods or services as consideration

for equity instruments of the entity (including shares or share options), or

– Acquires goods or services by incurring liabilities to the supplier of those goods or services for amounts that are based on the price of the entity’s shares or other equity instruments of the entity

Situations where the employee is dealing with the entity as a shareholder – Not covered by IFRS 2

When the transaction in question is a business combination– Covered by IFRS 3

8

IFRS 2 – Objective and Scope

9

IFRS 2 – Recognition

In general, the standard requires that the transaction be recognized when the goods are received or services rendered

The credit is booked to equity in an equity-settled transaction and the liability in a cash-settled transaction

The debit is booked to expense or asset (if the definition of an asset is met)

10

IFRS 2 – Equity-settled Share-based Payment Transactions

Overview For equity-settled transactions

– Transaction is measured at the fair value of the goods or services received– If the fair value cannot be reliably measured, then the fair value of the equity

instrument is used

There is a rebuttable presumption that the fair value of the goods and services may be reliably measured

– In most cases, the fair value of the equity instruments would not be used

An exception to this is where the transaction involves employees rendering services

– Transactions are measured by reference to the fair value of the equity instruments – May be too difficult to measure the services if the equity instruments are given to

the employee as part of the compensation/remuneration package for services normally rendered as an employee

11


Transactions in which services are received

Accounting might be affected by the vesting provisions

Share-based transactions such as options have conditions attached to them – Must be met before the counterparty has legal entitlement to them – Legal entitlement is referred to as vesting

Vesting– If the equity instruments vest upfront when the contract is entered into

The entity assumes that the services have already been provided and recognizes the full amount of the transaction at that date

– If the equity instruments vest over time The transaction is accrued and recognized over time

12


Transactions in which services are received (continued)

Options granted conditional upon the employee achieving certain goals – Vesting period must also be conditional upon achieving those goals– Entity must estimate the vesting period in order to calculate the amount of expense

to recognize in each period– Estimate may be revised in a subsequent period as a change in estimate – If the condition is a market condition (such as the shares reaching a certain price)

no subsequent revision is allowed Market would have already included expectations about the future share price into the

current share price

13


Transactions measured by reference to the fair value of the equity

instruments granted

Determining the fair value of equity instruments granted

Estimated as at the measurement date based on market conditions and prices

Measurement date – Generally the grant date for transactions with employees – For other transactions, is the date that the goods are received or the services

rendered

Grant date – Generally the date that the contract is agreed to by both parties

14


15


Determining the fair value of equity instruments granted (continued)

Market values – If the equity instruments are publicly traded shares, they are available – If they are stock options, they may or may not be available

Options pricing models– Valuation techniques - often used– E.g., Black-Scholes and binomial models

Model inputs(a) Exercise price

(b) Life of the option

(c) Current price of the shares

(d) Expected volatility of the share price

(e) Dividends expected on the shares

(f) Risk-free interest rate.

16


Treatment of vesting conditions There may be certain conditions attached to the transaction that must be met before

the counterparty or employee has legal entitlement (i.e., before the instruments vest)

At the grant date– The transaction is recognized and measured but the vesting conditions are not factored

into the measurement

After the grant date– The transaction is remeasured for the change in the number of equity instruments due

to the conditions being met/not met, but not for the fair value of the equity instrument itself

Subsequent remeasurements are treated as a change in estimate in subsequent periods

Where the vesting condition is a market condition (such as a target share price) this is taken into account at the measurement date and the transaction is not subsequently remeasured

17


Treatment of non-vesting conditions Uncertainty might also be introduced with non-vesting conditions

– Number of equity instruments to be issued might vary depending on some future event

In these cases, the transaction is recognized and measured at the grant date and the uncertainty is factored in at that point

– No remeasurement after the vesting date

Treatment of a reload feature Contract may allow the entity to automatically issue new options when an old one is

exercised using shares to satisfy the exercise price – These are treated as new option grants and reload features are not taken into account

when estimating fair value

18


After vesting date After initial recognition upon vesting

– Equity-settled transactions are not remeasured even if the equity instruments are forfeited

– Entity may transfer amounts from one category of equity to another

If the fair value of the equity instrument cannot be reliably estimated Where the entity is required to measure the transaction at fair value, it may use the

intrinsic value

Intrinsic value – Difference between the fair value of the shares to which the counterparty has the right to

subscribe or which it has the right to receive, and the price the counterparty is required to pay for those shares

Transaction continues to be remeasured until the equity instrument is settled/exercised (or forfeited or lapses/expires)

Costs related to forfeitures after the vesting date would be reversed

19


Modifications to the terms and conditions

If the equity instrument is modified afterwards and the total fair value of the transaction is increased, then this additional amount is recognized

If the entity cancels or settles the grant of the equity instrument during the vesting period

– Treats this as an acceleration of the vesting period – Recognizes all remaining amounts

Any cash payments are treated as a repurchase of equity (deducted from equity) – Only exception is where the payment is greater than the fair value of the equity

instruments granted– Excess is charged to expense

Additional guidance is provided where new or replacement equity instruments are granted

20

IFRS 2 – Cash-settled Share-based Payment Transactions

Where the transaction will eventually be settled in cash– Liability is recognized – Transaction is measured at the fair value of the liability at the measurement date– Liability is subsequently remeasured at every reporting date– Additional expenses/income due to the remeasurement are booked to profit and loss

Share appreciation rights (SARs)

For transactions involving options/share appreciation rights the fair value of the liability is measured at the fair value of the options/SAR

– Under this type of contract, an employee is granted a certain number of rights as remuneration for services

– Rights allow the employee to be paid the excess of the market value of a share over a certain base price

– Excess may be paid in cash (which is most often the case) or in shares

21


22


Share appreciation rights (SARs) continued

Accounting may be inconsistent with IAS 32– In cases where the SAR may be settled in shares (according to the terms of the SAR)

Under IFRS 2– If the SAR is to be settled with shares (i.e., a variable number of shares) it is

accounted for as equity

• Measured at the fair value of the SAR at the grant date

• Credited to equity

• Not subsequently remeasured after vesting date

Under IAS 32– If the number of shares is variable, the instrument would be accounted for as a liability

23

IFRS 2 – Share-based Payment Transactions with Cash Alternatives

Share-based payment transactions in which the terms of the arrangement

provide the counterparty with a choice of settlement

Where the counterparty has the option to dictate settlement, it is beyond the control of the entity and a liability may exist

In reality, this is a compound instrument– Part debt (the right to demand payment in cash) – Part equity (the right to demand payment in shares)

For transactions other than with employees and where the entire transaction is measured at fair value of the goods/services

– The equity component is the difference between the total transaction value and fair value of the debt component

24


Share-based payment transactions in which the terms of the arrangement provide the counterparty with a choice of settlement (continued)

For other transactions, where the equity instrument is used to value the transaction

• Measure fair value of debt component• Measure the equity component (considering that the entity must forfeit the right to the shares if the counterparty exercises the option to be paid in cash)

As an added complexity, the entity must split the transaction into two parts– the debt part – the equity part

The debit side of the journal entry (the expense) is also split into two parts – The debt part is accounted for as a cash-settled transaction – The equity part as an equity-settled transaction

25


Share-based payment transactions in which the terms of the arrangement

provide the entity with a choice of settlement

Where the entity has the choice of settlement options, the entity determines whether it has a liability (a present obligation to settle in cash)

Where the choice has no commercial substance– A liability exists – The transaction is accounted for as a cash-settled transaction– Otherwise, it is accounted for as an equity-settled transaction

If the entity assumes equity settlement and subsequently settles in cash– This is treated as a share buyback or repurchase of an equity interest (debit equity)– Unless the settlement alternative is the one with the higher fair value, in which case

the excess is booked as expense

IFRS 2 – Disclosures The entity must disclose sufficient information for the users

– To understand the nature and extent of these transactions – To understand the impact on the profit or loss statement

Specific disclosures

(a) A description of each type of share-based payment arrangement that existed at any time during the period

(b) The number and weighted average exercise prices of share options for each of the following groups of options

(i) Outstanding at the beginning of the period

(ii) Granted during the period

(iii) Forfeited during the period

(iv) Exercised during the period

(v) Expired during the period

(vi) Outstanding at the end of the period

(vii) Exercisable at the end of the period26

IFRS 2 – Disclosures(c) For share options exercised during the period, the weighted average share price at

the date of exercise.

(d) For share options outstanding at the end of the period, the range of exercise prices and weighted average remaining contractual life.

Additional disclosures relating to fair value measurements and the impact on the profit or loss statement are required

27

28

Current GAAP Comparisons

Page 116 of 164 ofhttp://www.kpmg.co.uk/pubs/IFRScomparedtoU.S.GAAPAnOverview(2008).pdf


If fair value of received goods/services not reliably measurable, IFRS uses fair value of non-tradable equity instruments

Measurement dates for share-based payments differ Treatment of vesting conditions differs


Differences in dealing with modifications of awards

Cash-settled share-based payments measured at fair value of liability under IFRS (intrinsic value under Canadian GAAP)

Where counterparty has choice of settlement, IFRS requires treatment as cash settled transaction if entity has incurred a liability – compound instrument

31

Looking Ahead

Because the standard is fairly new and largely converged with U.S. GAAP, there are no plans to alter or amend this standard in the near future

32

End-of-Chapter Practice

33


34


Copyright © 2010 John Wiley & Sons, Inc. All rights reserved. Reproduction or translation of this work beyond that permitted

by Access Copyright is unlawful. Requests for further information should be addressed to the Permissions

Department, John Wiley & Sons Inc., 111 River Street, Hoboken, NJ 07030-5774, (201) 748-6011, fax (201) 748-6008, website

http://www.wiley.com/go/permissions. The purchaser may make back-up copies for his or her own use only and not for

distribution or resale. The author and the publisher assume no responsibility for errors, omissions, or damages caused by the

use of these programs or from the use of the information contained herein.

share-based payment: ifrs 2 wiecek and young ifrs primer chapter 29

Documents